DSIP (delta sleep-inducing peptide)
Availability Not yet prescribable · sold for research use only
What it is
DSIP is a nine-amino-acid peptide isolated in the 1970s from the blood of rabbits in induced slow-wave sleep, which is where the name comes from. Its formal drug name is emideltide. Half a century later its receptor has still not been identified, so the mechanism behind everything sold under this name remains unresolved.
Why people take it
Sleep is the load-bearing wall of a longevity plan, and the existing options are unappealing: sedatives that blunt the next day, or supplements that stop working. DSIP is bought as a signal rather than a sedative, by people who log enough hours and still wake unrestored, or whose schedules keep shifting across time zones.
How it's delivered
Some clinics advertise DSIP as a subcutaneous injection; it does not currently qualify for compounding. There is no approved DSIP product. FDA placed emideltide in its safety-risk category for compounding in September 2023. FDA's Pharmacy Compounding Advisory Committee reviewed it in July 2026: trade press reported a committee vote; FDA has not posted minutes or changed the list. DSIP is not covered by HHS's draft October 2026 interim compounding policy, which names six other peptides.
Where the evidence stands
Thin and old. The human studies are small European trials from the 1980s and early 1990s in chronic insomnia, and they disagree. One reported sleep normalising in nearly every patient across a series of injections; a double-blind study in 16 chronic insomniacs found better sleep efficiency and shorter latency but concluded that short-term DSIP is unlikely to be of major therapeutic benefit. Sample sizes were small, and none of this meets the standard modern sleep medicine applies. No trial has tested it in healthy adults chasing better recovery.
Estimated cost
- No approved or lawfully compounded product, so no reference price
- Not covered by insurance
Who offers it
We don't list providers for DSIP: there is no approved product and no lawful compounding route, so there is nothing we can point you to. Anything sold online is unregulated.
Go deeper
The Peptide Explorer entry carries the compound record, and the sleep and recovery guide separates the sleep, mitochondrial, and clinical-disease lanes that get sold together as recovery.
DSIP in the Peptide Explorer · Peptides for Sleep, Recovery, and Energy
Longevity.io is for educational purposes only and is not medical advice. Whether a sleep peptide belongs in a plan is a conversation for a clinician who knows the whole picture, and untreated sleep apnea is the first thing worth ruling out. Confirm eligibility, product source, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
